Analysis of gastric cancer medication by exploring fluorouracil drugs

Abstract. Gastric cancer (GC), as one of the most important types of cancer with a very high incidence rate in China, is in urgent need of treatment. China has made certain progress, such as the widespread use of fluorouracil and other drugs in the treatment of gastric cancer, as well as the use of various treatment methods such as surgery and chemotherapy. This article aims to explore the efficacy of fluorouracil drugs in the treatment of gastric cancer and their combined application with other drugs. By analyzing the correlation between peripheral blood platelet levels and the efficacy of oxaliplatin combined with fluorouracil chemotherapy in gastric cancer patients, as well as the effects of two chemotherapy regimens, docetaxel combined with oxaliplatin, tigio and docetaxel combined with cisplatin and fluorouracil, on advanced gastric cancer, it was found that fluorouracil drugs, as cell cycle inhibitors, have an inhibitory effect on cell division and have a significant effect in the treatment of gastric cancer. Future research can further deepen the combined application of fluorouracil drugs with other drugs to reduce complications and improve treatment effectiveness. It is suggested that future research should focus on in-depth exploration of targeted drug delivery, combined with new biotechnology, to improve the efficiency and accuracy of gastric cancer treatment.